Circulating interleukin-8 levels are associated with myocardial injury, left ventricular function and future clinical adverse events in patients with ST-elevation myocardial infarction.
Impact of LR11 as residual risk on long term clinical outcomes in patients with coronary artery disease treated with statin after first percutaneous coronary intervention
Activation of regulatory T cells in patients with myocardial infarction endows them with enhanced suppressive ability and pro-inflammatory phenotype and function
Speaker:
Associate Professor I. Dumitriu (Birmingham, GB)